Literature DB >> 1955336

The BRMD BOMAB phantom family.

G H Kramer1, L Burns, L Noel.   

Abstract

The Human Monitoring Laboratory (HML) has used the International Commission on Radiological Protection's Report on Reference Man and Canadian anthropomorphic data as guidance to design and construct a family of phantoms corresponding to Reference Man (PM), Reference Woman (PF), Reference Ten-Year-Old (P10), Reference Four-Year-Old (P4), Ninety-five Percentile Man (PM95), and Five Percentile Man (PM5). The PM series also has an accessory chest section (PMacc) to better simulate lung depositions. The phantoms are constructed from high-density polyethylene and fitted with end-recessed filling caps to minimize leakage problems. This paper describes the methodology of construction and presents data so that the phantoms can be reproduced. The phantoms have been used in Canada's National in-vivo Intercomparison Program, and results show that all Canadian in-vivo counting facilities have size-dependent calibrations. Selected data are presented to exemplify this dependence.

Entities:  

Mesh:

Year:  1991        PMID: 1955336     DOI: 10.1097/00004032-199112000-00025

Source DB:  PubMed          Journal:  Health Phys        ISSN: 0017-9078            Impact factor:   1.316


  3 in total

Review 1.  An exponential growth of computational phantom research in radiation protection, imaging, and radiotherapy: a review of the fifty-year history.

Authors:  X George Xu
Journal:  Phys Med Biol       Date:  2014-08-21       Impact factor: 3.609

2.  Use of Transportable Radiation Detection Instruments to Assess Internal Contamination from Intakes of Radionuclides Part II: Calibration Factors and ICAT Computer Program.

Authors:  Robert Anigstein; Richard H Olsher; Donald A Loomis; Armin Ansari
Journal:  Health Phys       Date:  2016-12       Impact factor: 1.316

3.  Considerations in assigning dose based on uncertainties from in vivo counting.

Authors:  G H Kramer
Journal:  Environ Health Perspect       Date:  1997-12       Impact factor: 9.031

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.